Clinical Trial Update: FNA Tumor Sampling for CD137 Modulation: A Pilot Study

View source ↗

Summary

Termination update for a pilot study evaluating FNA tumor sampling for CD137 modulation in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Adenocarcinoma
• Head and Neck Cancer
• Non-hodgkin Lymphoma

Snippet

Sponsor: Stanford University | Conditions: Head and Neck Cancer, Breast Cancer | Status: TERMINATED